XML 58 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Deferred Revenue
 12 Months Ended
Dec. 31, 2013
Deferred Revenue Disclosure [Abstract]  
Deferred Revenue
Deferred Revenue
Deferred revenue consists of the following:
 
As of December 31,
 
2013
 
2012
Current portion:
 
 
 
Received or receivable from Sanofi (see Note 4a)
$
12,815

 
$
17,022

Received or receivable from Bayer HealthCare (see Note 4b)
9,738

 
9,212

Received for technology license agreement (see Note 5)
23,572

 
23,572

Other
875

 
1,025

 
$
47,000

 
$
50,831

Long-term portion:
 
 

Received or receivable from Sanofi (see Note 4a)
$
76,522

 
$
76,520

Received or receivable from Bayer HealthCare (see Note 4b)
26,683

 
27,256

Received for technology license agreement (see Note 5)
80,994

 
104,566

 
$
184,199

 
$
208,342